Trending
Blood test that can detect breast cancer available in India now, know the cost
Meanwhile, the results of a study published in the Lancet Oncology journal showed the breast cancer patients who were given Capivasertib, developed by AstraZeneca, survived almost twice as long than those given the standard treatment alone.
